AS
ANIRBAN SARDAR
Central Institute of Medicinal and Aromatic Plants, CSIR-Central Drug Research Institute, Central Drug Research Institute
0000-0002-7840-1862
Employment
-
Central Institute of Medicinal and Aromatic Plants DBT-Research Associate2024 - Present
-
CSIR-Central Drug Research Institute Phd Scholar2019 - 2024
Education
-
Central Drug Research Institute PhD2019 - 2024
Projects & Funding
Projects & funding information is unavailable.
Publications (21)
- Functional inhibition of miR-204–5p elevated during lactation restores Runx2 and enhances osteogenesis in estrogen-deficient bone loss Save
- Increased intake of saturated fatty acids during adolescence impacts the endoplasmic reticulum to induce insulin resistance and compromised bone mineral density ameliorated by Withaferin A Save
- Comparison of Differences in Cell Migration during the Osteogenic and Adipogenic Differentiation of the Bone Marrow-Derived Stem Cells Save
- Fortified Withaferin A accelerates the transition from fibrovascular to bone remodeling phase during endochondral bone formation to promote ossification. Save
- Comparative assessment of flavonoid content in banana pulp and peel and their role in mitigating bone loss conditions and promoting osteoblast differentiation Save
- Enrichment of the major bioavailable molecule glucuronated flavone TMMG in Spinacia oleracea ameliorates cartilage degeneration at a lower dose in ACLT-induced osteoarthritis Save
- FDA-approved polypeptide PTH 1–34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health Save
- U50 488H KOR agonist reduces cartilage degradation, chondrocyte hypertrophy and bone loss in osteoarthritis Save
- Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model. Save
- INTERMITTENT PTH 1-34 MITIGATES PALMITIC ACID-INDUCED LIPOTOXICITY IN OSTEOBLAST CELLS AND ALLEVIATES OSTEOPOROSIS Save